Frazier Life Sciences SPAC II Prices Initial Public Offering

Frazier Life Sciences Acquisition Corp. II, a special purpose acquisition company, has priced its initial public offering at $10.00 per share, aiming to raise $75 million. Its Class A ordinary shares are set to begin trading on Nasdaq under "FLSC" on October 14, 2026, with the offering expected to close the following day. This marks its entry into public markets, providing capital for future acquisitions.